147 related articles for article (PubMed ID: 9330706)
1. Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue.
Ebert E; Werle B; Jülke B; Kopitar-Jerala N; Kos J; Lah T; Abrahamson M; Spiess E; Ebert W
Adv Exp Med Biol; 1997; 421():259-65. PubMed ID: 9330706
[TBL] [Abstract][Full Text] [Related]
2. Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.
Werle B; Schanzenbächer U; Lah TT; Ebert E; Jülke B; Ebert W; Fiehn W; Kayser K; Spiess E; Abrahamson M; Kos J
Oncol Rep; 2006 Oct; 16(4):647-55. PubMed ID: 16969475
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J
Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984
[TBL] [Abstract][Full Text] [Related]
4. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.
Kos J; Krasovec M; Cimerman N; Nielsen HJ; Christensen IJ; Brünner N
Clin Cancer Res; 2000 Feb; 6(2):505-11. PubMed ID: 10690531
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.
Heidtmann HH; Salge U; Abrahamson M; Bencina M; Kastelic L; Kopitar-Jerala N; Turk V; Lah TT
Clin Exp Metastasis; 1997 Jul; 15(4):368-81. PubMed ID: 9219725
[TBL] [Abstract][Full Text] [Related]
6. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cathepsins B, D and steffins A and B in laryngeal carcinoma.
Smid L; Strojan P; Budihna M; Skrk J; Vrhovec I; Zargi M; Kos J
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S150-3. PubMed ID: 9065652
[TBL] [Abstract][Full Text] [Related]
8. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM
J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051
[TBL] [Abstract][Full Text] [Related]
9. Cystein proteinase inhibitor stefin A as an indicator of efficiency of tumor treatment in mice.
Korolenko TA; Poteryaeva ON; Falameeva OV; Levina OA
Bull Exp Biol Med; 2003 Jul; 136(1):46-8. PubMed ID: 14534608
[TBL] [Abstract][Full Text] [Related]
10. Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens.
Turk V; Brzin J; Kotnik M; Lenarcic B; Popović T; Ritonja A; Trstenjak M; Begić-Odobasić L; Machleidt W
Biomed Biochim Acta; 1986; 45(11-12):1375-84. PubMed ID: 3495261
[TBL] [Abstract][Full Text] [Related]
11. Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy.
Calkins CC; Sameni M; Koblinski J; Sloane BF; Moin K
J Histochem Cytochem; 1998 Jun; 46(6):745-51. PubMed ID: 9603786
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.
Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Kos J; Skrk J
Clin Cancer Res; 2000 Mar; 6(3):1052-62. PubMed ID: 10741734
[TBL] [Abstract][Full Text] [Related]
13. Major differences in stability and dimerization properties of two chimeric mutants of human stefins.
Kenig M; Jerala R; Kroon-Zitko L; Turk V; Zerovnik E
Proteins; 2001 Mar; 42(4):512-22. PubMed ID: 11170205
[TBL] [Abstract][Full Text] [Related]
14. Tissue Levels of Stefin A and Stefin B in Hepatocellular Carcinoma.
Lin YY; Chen ZW; Lin ZP; Lin LB; Yang XM; Xu LY; Xie Q
Anat Rec (Hoboken); 2016 Apr; 299(4):428-38. PubMed ID: 26753874
[TBL] [Abstract][Full Text] [Related]
15. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases.
Lenarcic B; Krizaj I; Zunec P; Turk V
FEBS Lett; 1996 Oct; 395(2-3):113-8. PubMed ID: 8898076
[TBL] [Abstract][Full Text] [Related]
16. Stefin a and stefin B: markers for prognosis in operable squamous cell carcinoma of the head and neck.
Strojan P; Anicin A; Svetic B; Pohar M; Smid L; Kos J
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1335-41. PubMed ID: 17418975
[TBL] [Abstract][Full Text] [Related]
17. Stefin B, the major low molecular weight inhibitor in ovarian carcinoma.
Kastelic L; Turk B; Kopitar-Jerala N; Stolfa A; Rainer S; Turk V; Lah TT
Cancer Lett; 1994 Jul; 82(1):81-8. PubMed ID: 8033073
[TBL] [Abstract][Full Text] [Related]
18. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
[TBL] [Abstract][Full Text] [Related]
19. Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis.
Strojan P; Oblak I; Svetic B; Smid L; Kos J
Br J Cancer; 2004 May; 90(10):1961-8. PubMed ID: 15138478
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the secondary structures of stefins and cystatins, the low-molecular mass protein inhibitors of cysteine proteinases.
Sali A; Turk V
Biol Chem Hoppe Seyler; 1987 May; 368(5):493-9. PubMed ID: 3497644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
